Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1853.00 | 2319.50 | 0.7989 | 0.6986 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 1963.00 | 2319.50 | 0.8463 | 0.7714 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2346.00 | 2319.50 | 1.0114 | 1.0166 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2230.00 | 2319.50 | 0.9614 | 0.9436 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 1362.00 | 2319.50 | 0.5872 | 0.3578 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2312.00 | 2319.50 | 0.9968 | 0.9953 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 1250.00 | 894.42 | 2331.00 | 2319.50 | 1.0050 | 1.0072 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2557.00 | 2319.50 | 1.1024 | 1.1470 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 2376.00 | 2319.50 | 1.0244 | 1.0353 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 1250.00 | 894.42 | 1007.00 | 2319.50 | 0.4342 | 0.0901 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 2253.00 | 2319.50 | 0.9713 | 0.9581 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 892.00 | 2319.50 | 0.3846 | -0.0020 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 1250.00 | 894.42 | 872.00 | 2319.50 | 0.3759 | -0.0183 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2227.00 | 2319.50 | 0.9601 | 0.9417 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2436.00 | 2319.50 | 1.0502 | 1.0726 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 1209.00 | 2319.50 | 0.5212 | 0.2451 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 1460.00 | 2319.50 | 0.6295 | 0.4282 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 1250.00 | 894.42 | 2127.00 | 2319.50 | 0.9170 | 0.8779 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 1250.00 | 894.42 | 1020.00 | 2319.50 | 0.4398 | 0.1003 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2250.00 | 2319.50 | 0.9700 | 0.9562 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2034.00 | 2319.50 | 0.8769 | 0.8178 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4083.00 | 4282.00 | 0.9535 | 0.9176 | |
| SK-BR-3 | 0 | uM | 8 | 2500.00 | 1955.17 | 4195.00 | 4282.00 | 0.9797 | 0.9640 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 2500.00 | 1955.17 | 4241.00 | 4282.00 | 0.9904 | 0.9831 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 2500.00 | 1955.17 | 4187.00 | 4282.00 | 0.9778 | 0.9607 |